Axim Biotechnologies Inc. | Key People and Executives
George E. Anastassov
Chairman, President & Chief Executive Officer
Lekhram Changoer
Director & Chief Technology Officer
Philip A. van Damme
Director, Chief Scientific & Medical Officer
Blake N. Schroeder
Independent Director
John W. Huemoeller
Independent Director
Robert L. Cunningham
Independent Director
Timothy R. Scott
Independent Director
George E. Anastassov
Chairman, President & Chief Executive Officer
Robert T. Malasek
Chief Financial Officer & Secretary
Lekhram Changoer
Director & Chief Technology Officer
Philip A. van Damme
Director, Chief Scientific & Medical Officer
Blake N. Schroeder
Independent Director
John W. Huemoeller
Independent Director
Robert L. Cunningham
Independent Director
Timothy R. Scott
Independent Director
| Address |
45 Rockefeller Plaza
New York New York 10111
United States
|
|
Employees
|
- |
| Website |
http://www.aximbiotech.com |
| Updated |
07/08/2019 |
| AXIM Biotechnologies, Inc. engages in the research, development, and production of pharmaceutical, nutraceutical, cosmetic, and genetically controlled botanical products. The firm also involves in the extraction and purification of cannabinoids technologies based on its proprietary technologies. Its products include CBD-based controlled release chewing gum under CanChew brand; and a combination of CBD and THC gum that treats pain and spasticity associated with multiple sclerosis under MedChew Rx brand. |
